[1] KAPUR N K,THAYER K L,ZWECK E. Cardiogenic shock in the setting of acute myocardial infarction[J]. Meth Deb Card Vasc J,2020,16(1):16-21.
[2] DZUBUR A,GACIC E,MEKIC M. Comparison of patients with acute myocardial infarction according to age[J]. Med Arch,2019,73(1):23-27.
[3] MOUHAT B,PUTOT A,HANON O,et al. Low systolic blood pressure and mortality in elderly patients after acute myocardial infarction[J]. J Am Heart Assoc,2020,9(5): e013030.
[4] NAVARRO M A,GOSCH K L,SPERTUS J A,et al. Chronic kidney disease and health status outcomes following acute myocardial infarction[J]. J Am Heart Assoc,2016,5(5):e002772.
[5] HOSSAIN M A,COSTANZO E,COSENTINO J,et al. Contrast-induced nephropathy: pathophysiology,risk factors,and prevention[J].Saudi J Kidney Dis Transpl,2018,29(1):1-9.
[6] YANG S H,DU Y,ZHANG Y,et al. Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease:a prospective observational study[J]. BMJ Open,2017,7(6): e015041.
[7] ZHANG Y,JIN J L,CAO Y X,et al. Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease:a prospective,large cohort study[J]. J Transl Med,2020,18(1):373.
[8] NUNNS G R,MOORE E E,CHAPMAN M P,et al. The hypercoagulability paradox of chronic kidney disease: the role of fibrinogen[J]. Am J Surg,2017 ,214(6):1215-1218.
[9] WEBSTER A C,NAGLER E V,MORTON R L,et al. Chronic kidney disease[J]. Lancet,2017,389(10075):1238-1252.
[10] REED G W,ROSSI J E,CANNON C P. Acute myocardial infarction[J]. Lancet,2017,389(10065):197-210.
[11] STENGAARD C,S?覫RENSEN J T,RASMUSSEN M B,et al. Prehospital diagnosis of patients with acute myocardial infarction[J]. Diagnosis (Berl),2016,3(4):155-166.
[12] KIM C S,CHOI J S,PARK J W,et al. Concomitant renal insufficiency and diabetes mellitus as prognostic factors for acute myocardial infarction[J]. Cardiovasc Diabetol,2011,10:95.
[13] KANIC V,VOLLRATH M,KOMPARA G,et al. Women and acute kidney injury in myocardial infarction[J]. J Nephrol,2018,31(5):713-719.
[14] FIODORENKO-DUMAS ■,DUMAS I,MASTEJ K,et al. Receptor GP Ⅱb/Ⅲa as an indicator of risk in vascular events[J]. Clin Appl Thromb Hemost,2019,25:1076029619845056.
[15] COHEN M,VISVESWARAN G. Defining and managing patients with non-ST-elevation myocardial infarction: sorting through type 1 vs other types[J]. Clin Cardiol,2020,43(3):242-250.
[16] TIBAUT M,MEKIS D,PETROVIC D. Pathophysiology of myocardial infarction and acute management strategies[J]. Cardiovasc Hematol Agents Med Chem,2017,14(3):150-159.
[17] HUANG N,XIA X,LI J,et al. Plasma fibrinogen and mortality in patients undergoing peritoneal dialysis:a prospective cohort study[J]. BMC Nephrol,2020,21(1):349.
[18] NUNNS G R,MOORE E E,CHAPMAN M P,et al. The hypercoagulability paradox of chronic kidney disease:the role of fibrinogen[J]. Am J Surg,2017,214(6):1215-1218.
[19] LUYENDYK J P,SCHOENECKER J G,FLICK M J. The multifaceted role of fibrinogen in tissue injury and inflammation[J].Blood,2019,133(6):511-520.
[20] COBO G,LINDHOLM B,STENVINKEL P. Chronic inflammation in end-stage renal disease and dialysis[J]. Nephrol Dial Transplant,2018,33(suppl 3):35-40.
[1]段雯婷,马向红,李广平.QRS碎裂波对行介入治疗的急性心肌梗死患者不良心血管事件的影响[J].天津医科大学学报,2014,20(02):111.
DUAN Wen-ting,MA Xiang-hong,LI Guang-ping.Effect of fQRS on main adverse cardiac events in patients with acute myocardial infarction undergoing coronary intervention[J].Journal of Tianjin Medical University,2014,20(04):111.
[2]马长辉,杨万松.血清丙氨酸转氨酶与ST段抬高型心肌梗死的相关性研究[J].天津医科大学学报,2014,20(02):116.
MA Chang-hui,YANG Wan-song.Clinical study of serum alanine aminotransferase in patients with acute ST-segment elevation myocardial infarction[J].Journal of Tianjin Medical University,2014,20(04):116.
[3]杨寿娟,刘 寅,赵 茹.血小板减少症伴肺栓塞患者合并急性心肌梗死1例报道[J].天津医科大学学报,2014,20(06):496.
[4]张 坤,李广平,上官文锋.急诊PCI术对心肌梗死患者QTc、Tp-Te、Tp-Tec间期的影响[J].天津医科大学学报,2015,21(03):48.
ZHANG Kun,LI Guang-ping,SHANGGUAN Wen-feng.Effects of primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction at QTc , Tp-Te and Tp-Tec interval[J].Journal of Tianjin Medical University,2015,21(04):48.
[5]张 坤,李广平,上官文锋.急诊PCI术对心肌梗死患者QTc、Tp-Te、Tp-Tec间期的影响[J].天津医科大学学报,2015,21(01):48.
ZHANG Kun,LI Guang-ping,SHANGGUAN Wen-feng.Effects of primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction at QTc , Tp-Te and Tp-Tec interval[J].Journal of Tianjin Medical University,2015,21(04):48.
[6]宋温婷,李 秀,王丹丹,等.血浆脂蛋白相关磷脂酶A2对急性心肌梗死患者住院预后的影响[J].天津医科大学学报,2016,22(02):107.
SONG Wen-ting,LI Xiu,WANG Dan-dan,et al.Impact of 1ipoprotein-associated phospholipase A2 on adverse cardiovascular events in hospitalized patients with acute myocardial infarction[J].Journal of Tianjin Medical University,2016,22(04):107.
[7]王东昕,崔占前,郭星梅,等.BMI对行急诊PCI的超急期ST段抬高型心肌梗死患者预后的影响[J].天津医科大学学报,2016,22(03):234.
WANG Dong -xin,CUI Zhan -qian,GUO Xing -mei,et al.Impact of body mass index on prognosis in patients with Acute ST-segment elevation Myocardial Infarction after emergency percutaneous coronary intervention during Super urgent period[J].Journal of Tianjin Medical University,2016,22(04):234.
[8]白光辉,张云强,梁海青,等.急性心肌梗死患者的心率变异性特征分析[J].天津医科大学学报,2017,23(01):56.
BAI Guang-hui,ZHANG Yun-qiang,LIANG Hai-qing,et al.Amalysis on features of heart rate variability in patients with acute myocardial infarction[J].Journal of Tianjin Medical University,2017,23(04):56.
[9]阚晨星,马向红.不同性别老老年心肌梗死患者血脂水平及冠脉病变严重程度差异的分析[J].天津医科大学学报,2019,25(04):356.
KAN Chen-xing,MA Xiang-hong.Analysis of in blood lipid levels and severity of coronary lesions in elderly patients different genders with myocardial infarction[J].Journal of Tianjin Medical University,2019,25(04):356.
[10]杜春蕾,郭 牧,张云强,等.尼非卡兰和胺碘酮治疗急性心肌梗死新发房颤有效性和安全性对比研究[J].天津医科大学学报,2019,25(05):471.
DU Chun-lei,GUO Mu,ZHANG Yun-qiang,et al.Comparison of nifekalant and amiodarone in the treatment of new-onset atrial fibrillation in acute myocardial infarction patients[J].Journal of Tianjin Medical University,2019,25(04):471.